-DOCSTART- -X- O
Infections -X- _ O
by -X- _ O
multidrug-resistant -X- _ B-Patient
( -X- _ I-Patient
MDR -X- _ I-Patient
) -X- _ I-Patient
Gram-negative -X- _ I-Patient
organisms -X- _ I-Patient
( -X- _ I-Patient
GN -X- _ I-Patient
) -X- _ I-Patient
are -X- _ O
associated -X- _ B-Outcome
with -X- _ I-Outcome
a -X- _ I-Outcome
high -X- _ I-Outcome
mortality -X- _ I-Outcome
rate -X- _ I-Outcome
and -X- _ I-Outcome
present -X- _ I-Outcome
an -X- _ I-Outcome
increasing -X- _ I-Outcome
challenge -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
healthcare -X- _ I-Outcome
system -X- _ I-Outcome
worldwide. -X- _ I-Outcome
In -X- _ O
recent -X- _ O
years -X- _ O
, -X- _ O
increasing -X- _ O
evidence -X- _ O
supports -X- _ O
the -X- _ O
association -X- _ O
between -X- _ O
the -X- _ O
healthcare -X- _ B-Intervention
environment -X- _ I-Intervention
and -X- _ I-Intervention
transmission -X- _ I-Intervention
of -X- _ I-Intervention
MDRGN -X- _ I-Intervention
to -X- _ I-Intervention
patients -X- _ I-Intervention
and -X- _ I-Intervention
healthcare -X- _ I-Intervention
workers. -X- _ I-Intervention
To -X- _ O
better -X- _ O
understand -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
the -X- _ O
environment -X- _ O
in -X- _ O
transmission -X- _ O
and -X- _ O
acquisition -X- _ O
of -X- _ O
MDRGN -X- _ O
, -X- _ O
we -X- _ O
conducted -X- _ O
a -X- _ O
utilitarian -X- _ O
review -X- _ O
based -X- _ O
on -X- _ O
literature -X- _ O
published -X- _ O
from -X- _ O
2014 -X- _ O
until -X- _ O
2019 -X- _ O
. -X- _ O

